Kabiven (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The solution contains a balanced blend of essential amino acids that are directly infused into the bloodstream. These amino acids become available for protein synthesis, support nitrogen balance, and help meet the metabolic demands of patients who lack enteral intake.

The dose of Kabiven is individualized. A qualified prescriber determines the volume and rate of infusion based on the patient’s weight, clinical condition, and nutritional requirements. No fixed regimen is provided in public information.

Safety data for Kabiven in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Kabiven, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where required), and import documentation.

Kabiven offers a comprehensive essential‑amino‑acid profile in a single sterile solution, simplifying formulation compared with multi‑component mixes. It is comparable to other amino‑acid‑based parenteral nutrition products but may differ in concentration, stability, and specific amino‑acid ratios, which can influence compatibility with other nutrients.

Kabiven must be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the solution. Before use, inspect for particulate matter or discoloration and ensure aseptic technique during preparation and administration.

Kabiven is administered intravenously as a sterile solution for injection. It is typically infused through a central or peripheral venous catheter, with the rate and total volume prescribed by the treating physician based on the patient’s nutritional needs.

Serious risks include severe hypersensitivity reactions such as anaphylaxis, metabolic acidosis, hyperammonemia, and thrombophlebitis. Clinicians should monitor patients closely for signs of these events and be prepared to intervene promptly.

Kabiven should be avoided in patients with known hypersensitivity to any of its amino‑acid components, those with uncontrolled electrolyte disturbances, or individuals for whom intravenous nutrition is contraindicated. Clinical judgment is required for each case.